NASDAQ:BBOT | Cash Flow Statement | BridgeBio Oncology Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$56.45M
2026-03-31-$42.11M-$35.92M$24,000.00-$285.41M$295,000.00
2025-12-31-$38.8M-$42.23M$73,000.00$7.77M-$586,000.00
2025-09-30-$44.76M
2025-06-30-$28.44M
2025-03-31-$22.06M-$19.6M$162,000.00$15.37M-$404,000.00
2024-12-31-$19.69M-$15.04M$10,000.00$25.56M$52,000.00
2024-09-30-$17.32M
2024-06-30-$21.82M
2024-03-31-$15.44M-$617,999.00-$184M$186.46M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$134.04M-$113.89M$606,000.00$73.33M$383.4M
2024-12-31-$74.28M-$55.03M$49,000.00-$120.53M$206.29M
2023-12-31-$41,692.00